英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:


请选择你想看的字典辞典:
单词字典翻译
Agios查看 Agios 在百度字典中的解释百度英翻中〔查看〕
Agios查看 Agios 在Google字典中的解释Google英翻中〔查看〕
Agios查看 Agios 在Yahoo字典中的解释Yahoo英翻中〔查看〕





安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Agios
    Since our founding, Agios has been a pioneering leader in cellular metabolism, advancing therapies for patients with unmet needs Our mature and unique understanding of the science is foundational to our success and the connective thread that binds our people and our pipeline together
  • Pipeline – Agios
    Agios is committed to creating value for shareholders by creating value for patients and healthcare providers Find out how in our latest press releases and SEC filings, upcoming events and other resources for investors
  • Press Releases – Agios Pharmaceuticals, Inc.
    Agios Outlines 2026 Strategic Priorities and Key Milestones to Accelerate Rare Disease Portfolio Growth Read More PDF Version Jan 05, 2026 Agios to Present at the 44th Annual J P Morgan Healthcare Conference on January 14, 2026 Read More PDF Version Latest Earnings Call View Replay Latest Form 10-K View PDF Sign Up Corporate Responsibility
  • About Us - Agios
    Agios was founded in 2008 to unlock a new field of discovery in cellular metabolism This singular focus on metabolic disease has taken us from the development of precision therapies in oncology to pioneering new investigational medicines for the treatment of rare diseases
  • Medical – Agios
    At Agios, we are studying how PK activation could potentially benefit people with SCD PK activation modulates 2,3-diphosphoglycerate (2,3-DPG) levels in RBCs which reduces hemoglobin S polymerization and may inhibit subsequent RBC sickling
  • Our Medicines – Agios
    Agios offers the myAgios ® patient support services program as a single point of engagement for eligible patients, including access support, prescription fulfillment, financial assistance, disease education and community connections
  • Quarterly Results – Agios Pharmaceuticals, Inc.
    Agios Provides Business Update on Discovery Research Strategy and Pipeline, Progress on Clinical Programs, Commercial Launch Preparations and Reports First Quarter 2018 Financial Results at Investor Day
  • Contact – Agios
    Agios Pharmaceuticals 88 Sidney Street Cambridge, MA 02139-4169 Phone: 617-649-8600
  • History – Agios
    As we create the future of Agios together, we are building on our core values and pioneering leadership in cellular metabolism to advance our work on behalf of people with rare diseases
  • Inside Agios – Agios
    Find out what Agios is all about on this virtual tour of our space, led by sickle cell disease warrior DeMitrious Wyant We’re proud to be a place where science meets heart, and meaningful connections fuel new innovations





中文字典-英文字典  2005-2009